Jianmin Fang

Title: Innovations of Jianmin Fang

Introduction

Jianmin Fang is a prominent inventor based in Yantai, China, known for his significant contributions to the field of biotechnology. He holds a total of 9 patents, showcasing his innovative approach to developing medical solutions.

Latest Patents

One of his latest patents is titled "Anti PD-L1 antibody and use thereof." This invention provides a PD-L1 immunosuppressant, specifically a monoclonal antibody capable of targeting PD-L1. The patent also includes nucleotides, combinations of polynucleotides, expression vectors, and combinations of expression vectors encoding the antibody. Furthermore, it describes the use of this anti PD-L1 antibody, along with the mentioned components, in the preparation of a medicament for treating or preventing cancers. Another notable patent is "Linker for antibody-drug conjugates and its use." This invention offers a linker for preparing antibody-drug conjugates, which are utilized in medicaments for treating tumors. The linker is designed to couple with thiol or amino groups on the antibody, ensuring a uniform and structurally stable coupled product.

Career Highlights

Jianmin Fang has worked with notable companies such as Remegen, Ltd. and Remegen Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Throughout his career, Jianmin has collaborated with esteemed colleagues, including Jing Jiang and Dong Li. These partnerships have further enhanced his research and development efforts.

Conclusion

Jianmin Fang's innovative work in biotechnology, particularly in the development of antibody-based therapies, highlights his significant impact on the medical field. His patents reflect a commitment to advancing cancer treatment and improving patient outcomes.